Avid Bioservices (NASDAQ:CDMO) PT Lowered to $20.00 at Stephens

Avid Bioservices (NASDAQ:CDMO – Get Rating) had its price target lowered by Stephens from $24.00 to $20.00 in a report released on Thursday, The Fly reports. Separately, Royal Bank of Canada restated an outperform rating and set a $20.00 target price on shares of Avid Bioservices in a research report on Tuesday, March 14th. Avid […]

Related Keywords

Canada ,Danielr Hart ,Richardb Hancock , ,Us Bancorp ,Lakewood Asset Management ,Securities Exchange Commission ,Meeder Asset Management Inc ,Avid Bioservices Inc ,Royal Bank ,Avid Bioservices ,Get Rating ,Exchange Commission ,Director Richard ,Asset Management ,Financial Advisors ,Avid Bioservices Daily ,Nasdaq Cdmo ,Cdmo ,Medical ,Lower Price Target ,Stephens ,